{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:59:03Z","timestamp":1779926343929,"version":"3.53.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11325-026-03623-0","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:47:32Z","timestamp":1772113652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing metabolic-dysfunction associated steatotic liver disease in patients with obstructive sleep apnea: a cross-sectional study"],"prefix":"10.1007","volume":"30","author":[{"given":"Mohammed","family":"Al-Houqani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hamad","family":"Alzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-8931","authenticated-orcid":false,"given":"Adnan","family":"Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"4","key":"3623_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM et al (2023) The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77(4):1335\u20131347","journal-title":"Hepatology"},{"key":"3623_CR2","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin L, Cortez-Pinto H, Negro F et al (2018) Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol 69:718\u2013735","journal-title":"J Hepatol"},{"key":"3623_CR3","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3748\/wjg.v24.i14.1491","volume":"24","author":"I Mikolasevic","year":"2018","unstructured":"Mikolasevic I, Filipec-Kanizaj T, Mijic M et al (2018) Nonalcoholic fatty liver disease and liver transplantation\u2014where do we stand? World J Gastroenterol 24:1491\u20131506","journal-title":"World J Gastroenterol"},{"issue":"7","key":"3623_CR4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of nafld development and therapeutic strategies. Nat Med 24(7):908\u2013922","journal-title":"Nat Med"},{"issue":"9","key":"3623_CR5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H (2020) Nafld and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications. Gut 69(9):1691\u20131705","journal-title":"Gut"},{"key":"3623_CR6","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78:1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"3623_CR7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia MJ (2014) International classification of sleep disorders\u2014third edition: highlights and modifications. Chest 146:1387\u20131394","journal-title":"Chest"},{"key":"3623_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.15","volume":"1","author":"P L\u00e9vy","year":"2015","unstructured":"L\u00e9vy P, Kohler M, McNicholas WT et al (2015) Obstructive sleep apnoea syndrome. Nat Rev Dis Primers 1:15015","journal-title":"Nat Rev Dis Primers"},{"key":"3623_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/oby.20288","volume":"21","author":"SM Togeiro","year":"2013","unstructured":"Togeiro SM, Carneiro G, Ribeiro Filho FF et al (2013) Consequences of obstructive sleep apnea on metabolic profile: a population-based survey. Obesity 21:847\u2013851","journal-title":"Obesity"},{"key":"3623_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.metabol.2016.05.004","volume":"65","author":"J Aron-Wisnewsky","year":"2016","unstructured":"Aron-Wisnewsky J, Clement K, P\u00e9pin JL (2016) Nonalcoholic fatty liver disease and obstructive sleep apnea. Metabolism 65:1124\u20131135","journal-title":"Metabolism"},{"key":"3623_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.sleep.2022.04.006","volume":"95","author":"Y Ji","year":"2022","unstructured":"Ji Y, Liang Y, Mak JCW, Ip MSM (2022) Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease. Sleep Med 95:16\u201328","journal-title":"Sleep Med"},{"issue":"3","key":"3623_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11325-018-1625-7","volume":"22","author":"S Jin","year":"2018","unstructured":"Jin S, Jiang S, Hu A (2018) Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Sleep Breath 22(3):841\u2013851. https:\/\/doi.org\/10.1007\/s11325-018-1625-7","journal-title":"Sleep Breath"},{"issue":"1","key":"3623_CR13","doi-asserted-by":"publisher","first-page":"e14116","DOI":"10.1111\/eci.14116","volume":"54","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Wang Y, Liu W et al (2024) Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study. Eur J Clin Invest 54(1):e14116. https:\/\/doi.org\/10.1111\/eci.14116","journal-title":"Eur J Clin Invest"},{"key":"3623_CR14","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.2147\/NSS.S524675","volume":"17","author":"T Yu","year":"2025","unstructured":"Yu T, Zhou Y, Wu X, Fang Z, Liu C (2025) Association between obstructive sleep apnea and non-alcoholic fatty liver disease: epidemiological cross-sectional study and Mendelian randomization analysis. Nat Sci Sleep 17:1361\u20131376. https:\/\/doi.org\/10.2147\/NSS.S524675","journal-title":"Nat Sci Sleep"},{"issue":"6","key":"3623_CR15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00601-2018","volume":"51","author":"W Trzepizur","year":"2018","unstructured":"Trzepizur W, Boursier J, Le Vaillant M et al (2018) Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities. Eur Respir J 51(6):1800601","journal-title":"Eur Respir J"},{"issue":"5","key":"3623_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/obr.12020","volume":"14","author":"G Musso","year":"2013","unstructured":"Musso G, Cassader M, Olivetti C et al (2013) Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Obes Rev 14(5):417\u2013431","journal-title":"Obes Rev"},{"issue":"3","key":"3623_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1378\/chest.13-0938","volume":"145","author":"C Minville","year":"2014","unstructured":"Minville C, Hilleret MN, Tamisier R et al (2014) Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. Chest 145(3):525\u2013533","journal-title":"Chest"},{"issue":"4","key":"3623_CR18","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/hep.21593","volume":"45","author":"V Savransky","year":"2007","unstructured":"Savransky V, Nanayakkara A, Vivero A et al (2007) Chronic intermittent hypoxia predisposes to liver injury. Hepatology 45(4):1007\u20131013","journal-title":"Hepatology"},{"issue":"7","key":"3623_CR19","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1164\/rccm.201806-1109TR","volume":"199","author":"OA Mesarwi","year":"2019","unstructured":"Mesarwi OA, Loomba R, Malhotra A (2019) Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease. Am J Respir Crit Care Med 199(7):830\u2013841","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3623_CR20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41467-024-44946-4","volume":"15","author":"XB Zhang","year":"2024","unstructured":"Zhang XB, Zeng YC, Zeng HQ et al (2024) Gut microbiota dysbiosis in obstructive sleep apnea contributes to liver fibrosis progression. Nat Commun 15(1):742","journal-title":"Nat Commun"},{"issue":"2","key":"3623_CR21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2023.09.030","volume":"80","author":"L Yang","year":"2024","unstructured":"Yang L, Liu S, Liu J et al (2024) Adipocyte-derived exosomes from OSA patients promote liver steatosis via miR-455-3p\/TCONS_00039830 axis. J Hepatol 80(2):234\u2013246","journal-title":"J Hepatol"},{"key":"3623_CR22","unstructured":"Agha A OSA-MASLD risk assessment tool [Internet]. OSA-MASLD. 2025 [cited 2025 Aug 7]. Available from: https:\/\/osa-masld-risk.netlify.app\/"},{"issue":"4","key":"3623_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1164\/rccm.202005-1868OC","volume":"203","author":"SS Ng","year":"2021","unstructured":"Ng SS, Wong VW, Wong GL et al (2021) Continuous positive airway pressure does not improve nonalcoholic fatty liver disease in patients with obstructive sleep apnea. A randomized clinical trial. Am J Respir Crit Care Med 203(4):493\u2013501. https:\/\/doi.org\/10.1164\/rccm.202005-1868OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3623_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/crj.12554","volume":"12","author":"LD Chen","year":"2018","unstructured":"Chen LD, Lin L, Zhang LJ et al (2018) Effect of continuous positive airway pressure on liver enzymes in patients with obstructive sleep apnea: a meta-analysis. Clin Respir J 12(2):373\u2013381","journal-title":"Clin Respir J"},{"key":"3623_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpeds.2018.03.028","volume":"198","author":"SS Sundaram","year":"2018","unstructured":"Sundaram SS, Halbower AC, Klawitter J et al (2018) Treating obstructive sleep apnea and chronic intermittent hypoxia improves the severity of nonalcoholic fatty liver disease in children. J Pediatr 198:67\u201375","journal-title":"J Pediatr"},{"issue":"1","key":"3623_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ultrasmedbio.2015.08.009","volume":"42","author":"M Buttacavoli","year":"2016","unstructured":"Buttacavoli M, Gruttad\u2019Auria CI, Olivo M et al (2016) Liver steatosis and fibrosis in OSA patients after long-term CPAP treatment: a preliminary ultrasound study. Ultrasound Med Biol 42(1):104\u2013109","journal-title":"Ultrasound Med Biol"},{"key":"3623_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","volume":"391","author":"A Malhotra","year":"2024","unstructured":"Malhotra A, Grunstein RR, Fietze I et al (2024) Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med 391:1193\u20131205","journal-title":"N Engl J Med"},{"issue":"4","key":"3623_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s11325-018-1622-x","volume":"22","author":"X Liu","year":"2018","unstructured":"Liu X, Miao Y, Wu F et al (2018) Effect of CPAP therapy on liver disease in patients with OSA: a systematic review and meta-analysis. Sleep Breath 22(4):963\u2013972","journal-title":"Sleep Breath"},{"issue":"8","key":"3623_CR29","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ijo.2016.52","volume":"40","author":"A Blackman","year":"2016","unstructured":"Blackman A, Foster GD, Zammit G et al (2016) Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE sleep apnea randomized clinical trial. Int J Obes 40(8):1310\u20131319","journal-title":"Int J Obes"},{"key":"3623_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD et al (2024) A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med 390:497\u2013509","journal-title":"N Engl J Med"},{"issue":"22","key":"3623_CR31","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373(22):2117\u20132128","journal-title":"N Engl J Med"},{"issue":"12","key":"3623_CR32","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41366-023-01378-2","volume":"47","author":"M Hany","year":"2023","unstructured":"Hany M, Abouelnasr AA, Abdelkhalek MH, Ibrahim M, Aboelsoud MR, Hozien AI, Torensma B (2023) Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review. Int J Obes 47(12):1200\u20131213","journal-title":"Int J Obes"},{"issue":"1","key":"3623_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-09985-x","volume":"15","author":"X Jia","year":"2025","unstructured":"Jia X, Zou C, Lu N, Lu Q, Xie C (2025) Obstructive sleep apnea is related to metabolic dysfunction associated steatotic liver disease in type 2 diabetes mellitus. Sci Rep 15(1):24627. https:\/\/doi.org\/10.1038\/s41598-025-09985-x","journal-title":"Sci Rep"},{"issue":"2","key":"3623_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/apt.14112","volume":"46","author":"S Sookoian","year":"2017","unstructured":"Sookoian S, Pirola CJ (2017) Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther 46(2):85\u201395","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3623_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/30502071231220779","volume":"1","author":"V Ganakumar","year":"2025","unstructured":"Ganakumar V, Halebidu T, Goroshi M, Ghatnatti V (2025) Diagnosis and management of MASLD: an metabolic perspective of a multisystem disease. Int J Clin Metab Diabetes 1(1):45\u201357. https:\/\/doi.org\/10.1177\/30502071231220779","journal-title":"Int J Clin Metab Diabetes"},{"issue":"3","key":"3623_CR36","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/GME.0000000000002133","volume":"30","author":"A Jaroenlapnopparat","year":"2023","unstructured":"Jaroenlapnopparat A, Charoenngam N, Ponvilawan B, Mariano M, Thongpiya J, Yingchoncharoen P (2023) Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Menopause 30(3):348\u2013354","journal-title":"Menopause"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-026-03623-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11325-026-03623-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-026-03623-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:14:39Z","timestamp":1774462479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11325-026-03623-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3623"],"URL":"https:\/\/doi.org\/10.1007\/s11325-026-03623-0","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"16 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the United Arab Emirates University Human Medical Research Ethics Committee, with an approval number ERH_2023_3147, and with the 1964 Helsinki declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}},{"value":"None to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Non-financial disclosure"}},{"value":"No Conflicts of Interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"65"}}